Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Cancer Cytopathology
|
March 16, 2013
Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma
Guoping Cai, Rebecca Wong, David Chhieng, et al.
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo
Rituparna Das, Rakesh Verma, Mario Sznol, et al.
Cancer Research
|
May 15, 2012
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing
Azeet Narayan, Nicholas J Carriero, Scott N Gettinger, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2013
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti, Kurt A Schalper, Daniel E Carvajal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2013
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer
Kimberly L Johung, Xiaopan Yao, Fangyong Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 27, 2018
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer
Scott N Gettinger, Anna Wurtz, Sarah B Goldberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer
Jon Zugazagoitia, Yuting Liu, Maria Toki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial
Mark A Socinski, Thomas E Stinchcombe, Dominic T Moore, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Cancer Cytopathology
|
March 16, 2013
Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma
Guoping Cai, Rebecca Wong, David Chhieng, et al.
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo
Rituparna Das, Rakesh Verma, Mario Sznol, et al.
Cancer Research
|
May 15, 2012
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing
Azeet Narayan, Nicholas J Carriero, Scott N Gettinger, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2013
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti, Kurt A Schalper, Daniel E Carvajal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2013
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer
Kimberly L Johung, Xiaopan Yao, Fangyong Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 27, 2018
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer
Scott N Gettinger, Anna Wurtz, Sarah B Goldberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer
Jon Zugazagoitia, Yuting Liu, Maria Toki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial
Mark A Socinski, Thomas E Stinchcombe, Dominic T Moore, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 7